# Healthcare Industry Ecosystem The U.S. hospital system is a patchwork of nonprofit, government, and for-profit operators — and corporate operators, including [[Private Equity]] firms, play a significant and growing role. This page maps the **ownership structure** of American hospitals: who owns the beds, who answers to shareholders, who answers to no one, and how the financialization of care became a political flashpoint. **Core thesis:** Hospital ownership is not a neutral administrative detail. It is the material substrate of a political-economic argument — whether health care is a public good delivered through government and charitable institutions, or an asset class to be optimized for return. The U.S. is the rich-world outlier that chose "both, badly," and the for-profit and private-equity layers are where the [[Corporate Capture]] of care is most visible. → Sister hubs: [[Big Pharma]] (the drug-and-device side of the same industry), [[Pharmacy Benefit Managers]] (the middlemen), [[Rural Hospital Closures]] (the consequences at the margin). --- ## The Three Ownership Models Per [[KFF]] data, the U.S. has roughly **5,100+ hospitals**, split across three broad ownership types. Nonprofits are the plurality, but the for-profit and PE layers punch far above their numbers in market power and political salience. | Ownership model | Share of hospitals | Who runs them | Tax status | | --- | --- | --- | --- | | [[Nonprofit Hospital]] | ~58% | Charities, religious systems (many Catholic), academic medical centers, community systems | Tax-exempt; must reinvest surplus | | [[For-Profit Hospital]] | ~24% | Private corporations and publicly traded chains | Taxed; distributes profit to shareholders | | [[Government Hospital]] | ~18% | State, county, municipal governments; VA (federal); urban safety-net | Public | The shares move year to year as systems merge, divest, and convert, but the rough 58/24/18 split has been stable. See [[Nonprofit Hospital]], [[For-Profit Hospital]], and [[Government Hospital]] for the full breakdowns. --- ## The For-Profit Giants For-profit hospitals are heavily consolidated into a handful of publicly traded chains answerable to shareholders. The headline operator is [[HCA Healthcare]] — the largest U.S. health system by net patient revenue and beds. Note that several of these chains have been **shrinking their hospital footprints aggressively**, divesting inpatient facilities and pivoting toward higher-margin outpatient and ambulatory care. | Chain | Hospitals | Revenue | Direction | | --- | --- | --- | --- | | [[HCA Healthcare]] | ~190 | ~$71B (2024) | Largest system; steady | | [[Community Health Systems]] | ~65 | ~$12B | Shrinking fast (was ~188 in 2019) | | [[Tenet Healthcare]] | ~49 acute | ~$21B | Pivoting to ambulatory (USPI) | | [[Universal Health Services]] | ~28 acute + ~330 behavioral | ~$16B | Scale is in behavioral health | The pivot is itself a story: [[Tenet Healthcare]] now makes most of its money from ambulatory surgery centers rather than hospitals, [[Community Health Systems]] has divested roughly a third of its portfolio since 2019, and [[Universal Health Services]]' real scale is its 330-plus behavioral health facilities, not its 28 acute hospitals. The for-profit model rewards exiting unprofitable inpatient care — exactly the service lines (emergency, obstetrics, psychiatric, rural) that communities depend on. See [[Hospital Consolidation]]. --- ## Private Equity: The Newest and Most Controversial Operator Beyond the publicly traded chains, [[Private Equity]] firms have become major hospital operators. Per the [[Private Equity Stakeholder Project]] tracker (updated April 2025), roughly **488 U.S. hospitals are PE-owned** — about **8.5% of all private hospitals** and **22.6% of all for-profit hospitals**. Texas has the most (108); New Mexico has the highest concentration (~36%); over a quarter serve rural populations. Major PE hospital owners include [[Apollo Global Management]] ([[Lifepoint Health]], ScionHealth), Equity Group Investments (Ardent Health), and [[Bain Capital]] (Surgery Partners). The collapse of [[Steward Health Care]] — loaded with debt by [[Cerberus Capital Management]] before its 2024 bankruptcy — became the cautionary tale that drove a wave of state-level PE regulation. **The evidence.** A landmark JAMA study (Kannan, Bruch, and Song, *JAMA* 2023) compared 51 PE-acquired hospitals to 259 matched controls and found PE ownership was associated with a **25% increase in hospital-acquired adverse events** — a 27% rise in falls, a 38% rise in central-line infections, and roughly double the rate of surgical-site infections — even as such conditions were falling nationally. The critique: PE firms load acquired hospitals with debt, cut staffing, and close unprofitable service lines to maximize short-term returns, with rural and underserved communities bearing the worst of it. See [[Private Equity Hospital Rollup]] and [[Financialization]]. --- ## The "Nonprofit" Nuance "Nonprofit" does not mean no one profits. [[Nonprofit Hospital]] systems pay no taxes and collect charitable donations and government grants, yet many run enormous operating margins, pay executives lavishly, and behave in ways that closely resemble their for-profit competitors. Research (Agency for Healthcare Research and Quality) finds for-profit hospitals are significantly more likely to offer profitable service lines and shed unprofitable ones, with nonprofits occupying a middle ground rather than a categorically different one. The tax-exemption-versus-charity-care gap is a recurring target for both populist-left and populist-right critics. The biggest nonprofit systems — [[Ascension]], [[CommonSpirit Health]], and the large Catholic and academic systems — rival the for-profit chains in revenue and market leverage. The big for-profit chains are concentrated (HCA, Tenet and CHS alone hold about 8% of community hospital beds, per KFF in 2022), and the largest nonprofits add another concentrated tier on top of that. An earlier version of this page said the 17 largest for-profit systems control nearly 30% of non-federal hospitals; no source for that figure could be found (2026-10-06). See [[Hospital Consolidation]]. --- ## Government and Safety-Net Hospitals About 18% of hospitals are publicly owned — by states, counties, and municipalities ("County General"), plus the federally run VA system ([[Department of Veterans Affairs]]). Many urban [[Safety-Net Hospital]] facilities fall here and carry a disproportionate share of uncompensated and emergency care. This layer is the most exposed to budget politics: it depends on [[Medicaid]] reimbursement and public appropriations, making it the first casualty of [[Medicaid Work Requirements]], rate cuts, and the budget fights tracked in the vault's [[Budget Hub]]. --- ## Payers and Insurers: The Other Half of the Industry Hospital ownership answers "who owns the beds." The **payer** side answers "who controls the money" — and in the U.S. that power is concentrated in a handful of [[Managed Care]] conglomerates that sit between patients, providers, and drugmakers. Increasingly they are vertically integrated (see [[Vertical Integration]]), owning the insurer, the physician groups, and the [[Pharmacy Benefit Managers]] in one structure. | Payer | 2024 revenue | Center of gravity | | --- | --- | --- | | [[UnitedHealth Group]] | ~$448B (FY2025) | Largest; insurer + Optum + OptumRx | | [[Elevance Health]] | ~$175B | Largest for-profit Blue Cross; Medicaid + commercial | | [[Centene]] | ~$163B | Largest Medicaid managed care; ACA marketplace | | [[Humana]] | ~$118B | Medicare Advantage pure-play | | [[Kaiser Permanente]] | ~$116B | Integrated nonprofit (insurer + hospitals) | | [[CVS Health]] | ~$370B | Aetna + Caremark (largest PBM) + pharmacy | | [[Cigna]] | ~$247B | Evernorth + Express Scripts (PBM) | **Why it matters here.** The payer side is where the [[Corporate Capture]] critique turns into the most personal grievance: [[Claim Denial]], [[Prior Authorization]], and — in [[Medicare Advantage]] — [[Upcoding]] of risk scores to extract higher [[CMS]] payments. The December 2024 [[UnitedHealthcare CEO Shooting]] detonated cross-partisan rage at exactly these practices. The same conglomerates own the [[Pharmacy Benefit Managers]] that decide what insured patients pay for drugs, tying this directly to the [[Big Pharma]] hub. The federal role here is overwhelmingly as **payer-of-payers** ([[Medicare]], [[Medicaid]], [[CMS]]) — see below. --- ## Drug Pricing: The Third Leg If hospital ownership is "who owns the beds" and managed care is "who controls the money," **[[Drug Pricing]]** is "why Americans pay more for medicines than anyone on earth, and who captures the difference." There is no single U.S. drug price — there is a chain of prices, each set by a different actor incentivized to obscure the next: manufacturer **[[List Price]]** → PBM **[[Drug Rebate]]** for **[[Formulary]]** placement → insurer cost-sharing → pharmacy → patient. The same vertically integrated conglomerates ([[UnitedHealth Group]], [[CVS Health]], [[Cigna]]) own both the insurers and the [[Pharmacy Benefit Managers]] that set what patients pay. The reform fights of 2022–2026 run on two competing tracks: the statutory [[Drug Price Negotiation]] under the [[Inflation Reduction Act]] (first 10 Medicare prices effective 2026; GLP-1s and 14 others for 2027), and the executive-branch [[Most-Favored-Nation Drug Pricing Deals]] plus the TrumpRx direct-to-consumer platform. Monopoly-extension tactics — [[Patent Evergreening]], [[Pay-for-Delay]], and rebate walls blocking [[Biosimilar]]s — keep prices high in between. See [[Big Pharma]] (manufacturers), [[Pharmacy Benefit Managers]] (middlemen), and [[Drug Pricing]] (the full mechanism map). --- ## Why the U.S. Structure Is an Outlier This hybrid is distinctively American. Most wealthy countries deliver hospital care primarily through government ownership or tightly regulated nonprofits funded by universal insurance. The U.S. model — rooted in historical distrust of government, the growth of local private and religious institutions, and market-driven expansion — produced a system where ownership type is contested terrain rather than a settled question. The federal government's role is largely as **payer** ([[Medicare]], [[Medicaid]], [[CMS]]) rather than owner, which is precisely why drug pricing, reimbursement rates, and [[Medicare Advantage]] are the levers everyone fights over. --- ## Where This Connects in the KB - **Drugs and devices:** [[Big Pharma]] · [[Pharmacy Benefit Managers]] · [[FDA]] - **Drug pricing:** [[Drug Pricing]] · [[Drug Price Negotiation]] · [[List Price]] · [[Drug Rebate]] · [[Spread Pricing]] · [[Formulary]] · [[340B Drug Pricing Program]] · [[Patent Evergreening]] · [[Pay-for-Delay]] · [[Biosimilar]] · [[Medicare Part D]] · [[GLP-1 Drugs]] - **The payer side:** [[UnitedHealth Group]] · [[Elevance Health]] · [[Humana]] · [[Centene]] · [[CVS Health]] · [[Cigna]] · [[Kaiser Permanente]] - **Big Tech entrants:** [[Amazon Health]] (One Medical, Amazon Pharmacy) · [[Verily]] (Google/Alphabet) · [[Oracle Health]] (Cerner) — platform-scale [[Vertical Integration]] into care, pharmacy, and health data - **Payer practices:** [[Managed Care]] · [[Medicare Advantage]] · [[Vertical Integration]] · [[Prior Authorization]] · [[Claim Denial]] · [[Upcoding]] - **Policy and money:** [[Affordable Care Act]] · [[Medicare and Medicaid Act]] · [[Medicaid Work Requirements]] · [[Inflation Reduction Act]] - **Consequences and flashpoints:** [[Rural Hospital Closures]] · [[UnitedHealthcare CEO Shooting]] · [[Death Panels]] - **The financial logic:** [[Private Equity]] · [[Financialization]] · [[Corporate Capture]] · [[Regulatory Capture]] · [[Elite Capture]] - **Vocabulary:** [[Healthcare Lexicon]]